United States · Markets & Finance · Morningstar

Masimo's smartSET™ FDA Clearance Offers Breakthrough Innovation in Pulse Oximetry to Help Improve Critical Patient Outcomes

Published by Morningstar · United States 18 h ago

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring solutions, today announced FDA 510 (k) clearance for AFib…

Read the full article on Morningstar Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)

Also worth reading

CNBC

AI stocks plunge. Inflation heats up. Where we're still finding opportunities

Seeking Alpha

Earnings Scoreboard: 83% of S&P 500 early reporters beat EPS estimates as Y/Y profit growth hits 23 firms

Business Insider

I'm a Colorado local. If I had one day to show you my state, I'd skip Denver and take you to a city just west of it.

TechCrunch

Ember’s new temperature-controlled mug makes my nightly tea ritual even better

NYT Business

The Reporter Who Exposed Elizabeth Holmes on Nathan Fielder’s Documentary

Quartz